Artículos relacionados a Drug Discovery in Cancer Epigenetics (Translational...
Sinopsis
Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic.
"Sinopsis" puede pertenecer a otra edición de este libro.
Acerca de los autores
Dr. Gerda Egger is an Associate Professor of Epigenetics at the Clinical Institute of Pathology, Medical University of Vienna.
Dr. Paola Barbara Arimondo is the Director of the Unité de Service et de Recherche (USR n°3388) entitled “Epigenetic Targeting of Cancer –ETaC-“ which brings together basic and applied research – a joint laboratory of the Institut de Recherche Pierre Fabre (IRPF) and the CNRS. She is extremely experienced in researching regulatory pharmaceuticals and cancer epigenetics.
"Sobre este título" puede pertenecer a otra edición de este libro.
Comprar nuevo
Ver este artículo
EUR 120,49
EUR 17,30 gastos de envío desde Reino Unido a España
Destinos, gastos y plazos de envíoResultados de la búsqueda para Drug Discovery in Cancer Epigenetics (Translational...
Imagen de archivo
Drug Discovery in Cancer Epigenetics (Translational Epigenetics Series)
Publicado por
Academic Press 2016-02-05, 2016
ISBN 10: 0128022086
ISBN 13: 9780128022085
Nuevo
Tapa dura
Librería: Chiron Media, Wallingford, Reino Unido
Calificación del vendedor: 4 de 5 estrellas
Hardcover. Condición: New. Nº de ref. del artículo: 6666-ELS-9780128022085
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
Drug Discovery in Cancer Epigenetics
Librería: Revaluation Books, Exeter, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Hardcover. Condición: Brand New. 1st edition. 498 pages. 9.50x8.00x1.00 inches. In Stock. Nº de ref. del artículo: __0128022086
Cantidad disponible: 2 disponibles
Imagen de archivo
Drug Discovery in Cancer Epigenetics
Impresión bajo demandaLibrería: Brook Bookstore On Demand, Napoli, NA, Italia
Calificación del vendedor: 5 de 5 estrellas
Condición: new. Questo è un articolo print on demand. Nº de ref. del artículo: 8217d68e366f130cf6ec187fa1fb1b28
Cantidad disponible: Más de 20 disponibles
Imagen del vendedor
Drug Discovery in Cancer Epigenetics
Librería: moluna, Greven, Alemania
Calificación del vendedor: 5 de 5 estrellas
Condición: New. Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as bio. Nº de ref. del artículo: 151151580
Cantidad disponible: 1 disponibles
Imagen de archivo
Drug Discovery in Cancer Epigenetics
Publicado por
Elsevier Science Publishing Co Inc, 2015
ISBN 10: 0128022086
ISBN 13: 9780128022085
Nuevo
Tapa dura
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Hardback. Condición: New. New copy - Usually dispatched within 4 working days. 1200. Nº de ref. del artículo: B9780128022085
Cantidad disponible: Más de 20 disponibles
Imagen del vendedor
Drug Discovery in Cancer Epigenetics
Publicado por
Elsevier Science Dez 2015, 2015
ISBN 10: 0128022086
ISBN 13: 9780128022085
Nuevo
Tapa dura
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Calificación del vendedor: 5 de 5 estrellas
Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic. 498 pp. Englisch. Nº de ref. del artículo: 9780128022085
Cantidad disponible: 2 disponibles
Imagen del vendedor
Drug Discovery in Cancer Epigenetics
Impresión bajo demandaLibrería: AHA-BUCH GmbH, Einbeck, Alemania
Calificación del vendedor: 5 de 5 estrellas
Buch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic. Nº de ref. del artículo: 9780128022085
Cantidad disponible: 2 disponibles